Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Proposed Risk Score Prioritizes Sickest Patients for Heart Transplant

By HospiMedica International staff writers
Posted on 16 Oct 2026

Donor hearts remain extremely scarce in the U. More...

S. transplant system, with one in five candidates dying or being removed from the waiting list before receiving an organ. Current allocation rules may also be influenced by treatment decisions rather than objective measures of medical urgency. To support more consistent prioritization, researchers have proposed a heart allocation policy based on laboratory measures of advanced heart failure.

Researchers from the University of Chicago developed the proposed policy in collaboration with federal policymakers. The approach uses the U.S. Candidate Risk Score (US-CRS), a measure designed to predict whether a patient will die without a heart transplant within six weeks of being placed on the waiting list. The proposal was described in a paper published in JAMA on October 12, 2026.

The current U.S. heart allocation system uses a six-status model. It places patients into severity levels based on treatments they are receiving, including mechanical circulatory support devices or aortic balloon pumps. Because treatment choices can be subjective, the system may create incentives to use more aggressive therapies to improve a patient’s waiting-list priority.

US-CRS still considers treatments, but it also incorporates clinical and laboratory measurements linked to end-stage heart failure. These include blood-based markers associated with heart, liver and kidney failure. The resulting score is intended to identify the sickest patients through more objective measures.

The policy was evaluated in an analysis of more than 45,000 match runs that generate ranked lists of transplant candidates. In that analysis, the new system prioritized the sickest patients for transplant more effectively than the current treatment-based system. Collaboration with the Scientific Registry of Transplant Recipients, the Health Resources and Services Administration, and the Organ Procurement and Transplant Network heart committee helped adapt the model toward policy use.

The team also developed a heart allocation algorithm that accounts for operational factors such as the distance between the donor and candidate. Additional administrative review, testing and revision are still needed before the policy could be adopted nationally.

“Our match run analysis of an actual novel policy is strongly suggestive that if we move from the current system to this policy, we could save even more lives with heart transplant. We took a really important step closer to the goal of developing an objective medical urgency score for heart transplant,” said William F. Parker, M.D., Ph.D., associate professor of medicine and public health sciences at UChicago and senior author of the study.

“Working directly with key policymakers was good because they gave us critical feedback about making this a practical reality. My dream would be that we can implement this within a few years, so we lose fewer patients and finally have a more fair system that doesn't depend on arbitrary subjective decision making but instead reflects the true medical urgency of the heart transplant candidates,” Parker added.

Related Links
University of Chicago


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hybrid Arch Device
Neo EDE
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Credit: MedUni Wien/Houdek

New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation

When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. This can lead to patient-prosthesis mismatch, causing... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: The tool analyzes 3D time-of-flight MR angiography to measure brain vessel length, radius, volume, branching, tortuosity, and other structural features. (Photo courtesy of University of Rochester Medical Center)

MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease

Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.